Mativ HoldingsNYSE: MATV

ALPHARETTA, Ga.--(BUSINESS WIRE)--Mativ Holdings, Inc. (NYSE: MATV) today announced it has appointed John K. Stipancich as an independent member of its board of directors, effective June 13, 2024, for a term of office expiring at the 2027 annual meeting. In connection with his appointment, Stipancich has also been appointed to serve on the Board's audit committee. “We're pleased to welcome John to the Board. With over 30 years of experience, he brings a deep well of legal, operational, and fina.

Mativ Holdings, Inc. (NYSE: MATV) has announced that it will report its first quarter 2024 financial results on May 8, 2024, after the market closes. A conference call to review these results is set for 8:30 a.m. ET on May 9, 2024. The call can be joined via webcast or telephone. A replay of the call will be available on the Investors section of Mativ's website at ir.mativ.com following the webcast.

Investors interested in Chemical - Specialty stocks may want to consider Mativ Holdings (MATV) or Novozymes A/S (NVZMY). The question is, which of these two stocks provides better value for value investors currently?

Investors interested in Chemical - Specialty stocks are likely familiar with Mativ Holdings (MATV) and Novozymes A/S (NVZMY). But which of these two stocks offers value investors a better bang for their buck right now?

Investors interested in stocks from the Chemical - Specialty sector have probably already heard of Mativ Holdings (MATV) and Novozymes A/S (NVZMY). But which of these two stocks offers value investors a better bang for their buck right now?

Investors looking for stocks in the Chemical - Specialty sector might want to consider either Mativ Holdings (MATV) or Novozymes A/S (NVZMY). But which of these two stocks offers value investors a better bang for their buck right now?

ALPHARETTA, Ga.--(BUSINESS WIRE)--Mativ Holdings, Inc. (NYSE: MATV) will issue a press release announcing the Company's third quarter 2023 results after the market closes on November 8, 2023 and hold a conference call to discuss results on November 9, 2023. Mativ will use a presentation to accompany its conference call. The presentation can be found on the Company's Web site in advance of the earnings conference call. The presentation can also be accessed via the earnings conference call webcas.

MATV remains a hold due to negative cash flows and challenged volume levels. Investors seeking value should look elsewhere. The company's margins have improved, but FCF growth and volume growth are needed for an upgraded rating.

Mativ Holdings, Inc. has grown sales exponentially YoY as a result of a merger that happened last year. The first quarter of the year had Mativ Holdings, Inc. face many challenges, and I won't make an investment case for the company until there is more clarity, especially the margins.